Trial Outcomes & Findings for Cerebellar Transcranial Direct Current Stimulation in Parkinson's Disease (NCT NCT04046055)
NCT ID: NCT04046055
Last Updated: 2022-11-10
Results Overview
Walk as fast and as safe as possible over 30 meter
COMPLETED
NA
7 participants
10 minutes
2022-11-10
Participant Flow
All subjects in this study completed all of the study arms (repeated-measure design).
Participant milestones
| Measure |
Sham/2mA/ Unilateral 2 mA/ Bilateral 2 mA/ Unilateral 4 mA /Bilateral 4 mA)
Sham transcranial direct current stimulation: Uses weak electrical current (2 mA intensity) at the beginning and the end of a given stimulation period to control for potential placebo-like effects or participant expectation bias.
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 2 mA or 4 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA/4mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
|---|---|
|
Overall Study
STARTED
|
7
|
|
Overall Study
Sham
|
7
|
|
Overall Study
Unilateral, 2 mA
|
7
|
|
Overall Study
Bilateral, 2 mA
|
7
|
|
Overall Study
Unilateral, 4 mA
|
7
|
|
Overall Study
Bilateral, 4 mA
|
7
|
|
Overall Study
COMPLETED
|
7
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Sham, Unilateral 2 mA, Bilateral 2 mA, Unilateral 4 mA, and Bilateral 4 mA)
n=7 Participants
Sham transcranial direct current stimulation: Uses weak electrical current (2 mA intensity) at the beginning and the end of a given stimulation period to control for potential placebo-like effects or participant expectation bias.
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA/4mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA/4mA for the remainder of the stimulation time.
|
|---|---|
|
Age, Continuous
|
72.4 years
STANDARD_DEVIATION 6.4 • n=7 Participants
|
|
Sex: Female, Male
Female
|
2 Participants
n=7 Participants
|
|
Sex: Female, Male
Male
|
5 Participants
n=7 Participants
|
|
Region of Enrollment
United States
|
7 Participants
n=7 Participants
|
|
UPDRS-III
|
32.6 Scores on scale
STANDARD_DEVIATION 14.2 • n=7 Participants
|
PRIMARY outcome
Timeframe: 10 minutesWalk as fast and as safe as possible over 30 meter
Outcome measures
| Measure |
Sham 4 mA
n=7 Participants
Sham transcranial direct current stimulation: Uses weak electrical current (2 mA intensity) at the beginning and the end of a given stimulation period to control for potential placebo-like effects or participant expectation bias.
|
Unilateral 2 mA
n=7 Participants
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Bilateral 2 mA
n=7 Participants
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Unilateral 4 mA
n=7 Participants
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 4 mA over the first 30 seconds and stays at 4 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 4 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Bilateral 4 mA
n=7 Participants
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 4 mA over the first 30 seconds and stays at 4 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 4 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
|---|---|---|---|---|---|
|
Speed Walked During 30 Meter Walk Test
|
5.63 meters per second (m/s)
Standard Deviation 0.84
|
5.65 meters per second (m/s)
Standard Deviation 1.04
|
5.77 meters per second (m/s)
Standard Deviation 1.07
|
5.86 meters per second (m/s)
Standard Deviation 1.06
|
5.77 meters per second (m/s)
Standard Deviation 1.24
|
PRIMARY outcome
Timeframe: 10 minutesFrom a seated position, stand up, walk 5 meters, turn around, walk back, and sit back down in the chair.
Outcome measures
| Measure |
Sham 4 mA
n=7 Participants
Sham transcranial direct current stimulation: Uses weak electrical current (2 mA intensity) at the beginning and the end of a given stimulation period to control for potential placebo-like effects or participant expectation bias.
|
Unilateral 2 mA
n=7 Participants
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Bilateral 2 mA
n=7 Participants
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Unilateral 4 mA
n=7 Participants
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 4 mA over the first 30 seconds and stays at 4 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 4 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Bilateral 4 mA
n=7 Participants
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 4 mA over the first 30 seconds and stays at 4 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 4 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
|---|---|---|---|---|---|
|
Time to Complete the Timed Up and Go Test
|
11.9 seconds (s)
Standard Deviation 2.7
|
12.43 seconds (s)
Standard Deviation 2.32
|
12.80 seconds (s)
Standard Deviation 2.42
|
12.42 seconds (s)
Standard Deviation 2.72
|
12.70 seconds (s)
Standard Deviation 3.28
|
PRIMARY outcome
Timeframe: 1 minuteStand as still as possible on a firm surface for 1 minute with the eyes open. Calculate the area of an ellipse that contains 95% of the 2D trace of the center of pressure movement.
Outcome measures
| Measure |
Sham 4 mA
n=7 Participants
Sham transcranial direct current stimulation: Uses weak electrical current (2 mA intensity) at the beginning and the end of a given stimulation period to control for potential placebo-like effects or participant expectation bias.
|
Unilateral 2 mA
n=7 Participants
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Bilateral 2 mA
n=7 Participants
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Unilateral 4 mA
n=7 Participants
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 4 mA over the first 30 seconds and stays at 4 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 4 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Bilateral 4 mA
n=7 Participants
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 4 mA over the first 30 seconds and stays at 4 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 4 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
|---|---|---|---|---|---|
|
Movement of the Center of Pressure (2D; Forward-backward, Left-right) While Standing on a Firm Surface (Force Platform) for 1 Minute
|
3.22 centimeters squared (cm^2)
Standard Deviation 2.56
|
2.47 centimeters squared (cm^2)
Standard Deviation 2.34
|
1.72 centimeters squared (cm^2)
Standard Deviation 0.50
|
1.60 centimeters squared (cm^2)
Standard Deviation 0.74
|
1.57 centimeters squared (cm^2)
Standard Deviation 0.39
|
PRIMARY outcome
Timeframe: 1 minuteStand as still as possible on a foam surface for 1 minute with the eyes open. Calculate the area of an ellipse that contains 95% of the 2D trace of the center of pressure movement.
Outcome measures
| Measure |
Sham 4 mA
n=7 Participants
Sham transcranial direct current stimulation: Uses weak electrical current (2 mA intensity) at the beginning and the end of a given stimulation period to control for potential placebo-like effects or participant expectation bias.
|
Unilateral 2 mA
n=7 Participants
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Bilateral 2 mA
n=7 Participants
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Unilateral 4 mA
n=7 Participants
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 4 mA over the first 30 seconds and stays at 4 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 4 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Bilateral 4 mA
n=7 Participants
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 4 mA over the first 30 seconds and stays at 4 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 4 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
|---|---|---|---|---|---|
|
Movement of the Center of Pressure (2D; Forward-backward, Left-right) While Standing on a Foam Surface (6 cm Foam Pad Placed on Top of Force Platform) for 1 Minute
|
8.34 centimeters squared (cm^2)
Standard Deviation 7.57
|
7.53 centimeters squared (cm^2)
Standard Deviation 4.35
|
9.36 centimeters squared (cm^2)
Standard Deviation 6.90
|
8.30 centimeters squared (cm^2)
Standard Deviation 6.40
|
7.60 centimeters squared (cm^2)
Standard Deviation 3.63
|
SECONDARY outcome
Timeframe: 1 minuteStand as still as possible on a firm surface for 1 minute with the eyes open.
Outcome measures
| Measure |
Sham 4 mA
n=7 Participants
Sham transcranial direct current stimulation: Uses weak electrical current (2 mA intensity) at the beginning and the end of a given stimulation period to control for potential placebo-like effects or participant expectation bias.
|
Unilateral 2 mA
n=7 Participants
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Bilateral 2 mA
n=7 Participants
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Unilateral 4 mA
n=7 Participants
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 4 mA over the first 30 seconds and stays at 4 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 4 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Bilateral 4 mA
n=7 Participants
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 4 mA over the first 30 seconds and stays at 4 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 4 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
|---|---|---|---|---|---|
|
Movement of the Center of Pressure (1D; Forward-backward) While Standing on a Firm Surface (Force Platform) for 1 Minute
|
2.38 centimeters (cm)
Standard Deviation 0.70
|
2.90 centimeters (cm)
Standard Deviation 0.91
|
2.25 centimeters (cm)
Standard Deviation 0.62
|
2.25 centimeters (cm)
Standard Deviation 0.69
|
2.86 centimeters (cm)
Standard Deviation 1.02
|
SECONDARY outcome
Timeframe: 1 minuteStand as still as possible on a firm surface for 1 minute with the eyes open.
Outcome measures
| Measure |
Sham 4 mA
n=7 Participants
Sham transcranial direct current stimulation: Uses weak electrical current (2 mA intensity) at the beginning and the end of a given stimulation period to control for potential placebo-like effects or participant expectation bias.
|
Unilateral 2 mA
n=7 Participants
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Bilateral 2 mA
n=7 Participants
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Unilateral 4 mA
n=7 Participants
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 4 mA over the first 30 seconds and stays at 4 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 4 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Bilateral 4 mA
n=7 Participants
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 4 mA over the first 30 seconds and stays at 4 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 4 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
|---|---|---|---|---|---|
|
Movement of the Center of Pressure (1D; Left-Right) While Standing on a Firm Surface (Force Platform) for 1 Minute
|
2.1 centimeters (cm)
Standard Deviation 1.8
|
1.4 centimeters (cm)
Standard Deviation 0.6
|
1.3 centimeters (cm)
Standard Deviation 0.3
|
1.1 centimeters (cm)
Standard Deviation 0.4
|
1.1 centimeters (cm)
Standard Deviation 0.4
|
SECONDARY outcome
Timeframe: 1 minuteStand as still as possible on a foam surface for 1 minute with the eyes open.
Outcome measures
| Measure |
Sham 4 mA
n=7 Participants
Sham transcranial direct current stimulation: Uses weak electrical current (2 mA intensity) at the beginning and the end of a given stimulation period to control for potential placebo-like effects or participant expectation bias.
|
Unilateral 2 mA
n=7 Participants
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Bilateral 2 mA
n=7 Participants
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Unilateral 4 mA
n=7 Participants
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 4 mA over the first 30 seconds and stays at 4 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 4 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Bilateral 4 mA
n=7 Participants
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 4 mA over the first 30 seconds and stays at 4 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 4 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
|---|---|---|---|---|---|
|
Movement of the Center of Pressure (1D; Forward-backward) While Standing on a Foam Surface (6 cm Foam Pad Placed on Top of Force Platform) for 1 Minute
|
4.4 centimeters (cm)
Standard Deviation 2.8
|
4.0 centimeters (cm)
Standard Deviation 1.1
|
4.5 centimeters (cm)
Standard Deviation 1.8
|
4.11 centimeters (cm)
Standard Deviation 1.41
|
4.08 centimeters (cm)
Standard Deviation 1.19
|
SECONDARY outcome
Timeframe: 1 minuteStand as still as possible on a foam surface for 1 minute with the eyes open.
Outcome measures
| Measure |
Sham 4 mA
n=7 Participants
Sham transcranial direct current stimulation: Uses weak electrical current (2 mA intensity) at the beginning and the end of a given stimulation period to control for potential placebo-like effects or participant expectation bias.
|
Unilateral 2 mA
n=7 Participants
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Bilateral 2 mA
n=7 Participants
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 2 mA over the first 30 seconds and stays at 2 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 2 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Unilateral 4 mA
n=7 Participants
A unilateral cerebellar montage with the anode three cm lateral to the inion on the side ipsilateral to the more PD-affected side and the cathode on the ipsilateral cheek. Stimulation is ramped up to 4 mA over the first 30 seconds and stays at 4 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 4 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
Bilateral 4 mA
n=7 Participants
Bilateral cerebellar tDCS will have both electrodes placed 3 cm to either side of the inion, with the anode assigned to the most PD-affected side and the cathode assigned to the less PD-affected side. Stimulation is ramped up to 4 mA over the first 30 seconds and stays at 4 mA for the remainder of the stimulation time.
Transcranial direct current stimulation at 4 mA: Uses weak electrical current to either increase or decrease brain excitability and improve functional or cognitive outcomes.
|
|---|---|---|---|---|---|
|
Movement of the Center of Pressure (1D; Left-Right) While Standing on a Foam Surface (6 cm Foam Pad Placed on Top of Force Platform) for 1 Minute
|
3.6 centimeters (cm)
Standard Deviation 1.8
|
3.4 centimeters (cm)
Standard Deviation 1.0
|
3.3 centimeters (cm)
Standard Deviation 1.3
|
3.3 centimeters (cm)
Standard Deviation 1.2
|
3.3 centimeters (cm)
Standard Deviation 1.0
|
Adverse Events
Sham
Unilateral, 2 mA
Bilateral, 2 mA
Unilateral, 4 mA
Bilateral, 4 mA
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place